🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

"Genetic versus self-reported African ancestry of the recipient and neighborhood predictors of kidney transplantation outcomes in 2 multiethnic urban cohorts" by Zanoni et al. doi.org/10.1016/j.ajt.…

Following Dr. Whittier’s discussion on TRF Budesonide at #GlomConHawaii , explore this visual abstract that captures the key clinical trial outcomes—reductions in proteinuria and stable kidney function. GlomCon Bill Whittier

Just after a powerful lupus nephritis session by Dr. Brad H Rovin at #GlomConHawaii2024. These unique LN cases of non-ESKD calciphylaxis really hit close to home—eye-opening data and outcomes captured in this visual abstract. GlomCon GlomCon Ibero-LatinoAmérica

The #TURING protocol paper has been published in BMC Nephrology bmcnephrol.biomedcentral.com/articles/10.11… It is time to recognise glucocorticoid toxicity in podocytopathies and use less GC. Investigators could choose between two GC regimens. pubmed.ncbi.nlm.nih.gov/38341276/ NDT

Clinical Management of C3/TMA 🗣️ Dr. Carla Nester 🩺 When to suspect complement mediated TMA? 🔵 Family Hx 🔵Prior personal hx 🔵Pathogenic variant in a classic gene 🩺 Why are 🧬 important? 🔵Diagnosis 🔵Help to decide what to do #GlomConHawaii

Clinical Management of C3/TMA 🗣️ Dr. Carla Nester C3G 🩺 When C3 is in the ddx - rule out infection 🦠 🩺⬆️ disease burden 🩺If patient is older - it is paraprotein until proven otherwise 🩺Current tx recommendations 📷⬇️ #GlomConHawaii

Dr Nester’s 🦚 of TMA 🌺#GlomConHawaii 🌺 ⬇️⬇️⬇️⬇️

The new generation of B cell–targeting therapies for the treatment of autoimmune kidney diseases Watch the author present his paper here: 🆓doi.org/10.1093/ndt/gf…

The survey results show pharmacists were more likely to make any adjustments to GDMT than internists and cardiologists. OPEN ACCESS buff.ly/3WhGRvH ACCP Cardiology PRN

Inhibition of complement factor C5a or C5aR for cholesterol crystal embolism-related vascular thrombosis with microvascular injury and its consequences - Kidney International kidney-international.org/article/S0085-…

Hi everyone! Check out the July issue featuring as cover the work from Esteban CORTES GARCIA Alexandre Loupy Olivier Aubert et al describing the use of NGS in kidney transplant biopsies to identify molecular signatures of rejection👉 fro.ntiers.in/TI_July ESOTtransplant Paris Transplant Group

IgA Nephropathy (IgAN): Treatment Pillars ca. 2024 from MDPI Jonathan Barratt Dana Rizk #Nephpearls 📌 Optimal supportive care 1⃣ Mitigating consequences of ongoing nephron loss 2⃣ Halting glomerular inflammation 3⃣ Reducing production of Gd-IgA1 4⃣ Stopping

#TBT to this week's featured top downloaded paper from 2022: Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review #Transplantation #Med tinyurl.com/2fzft8zn

Cohosts Roslyn Mannon (moving to Bluesky as mannonmom) and Josh Levitsky are joined by Maria Alejandra Mendoza to discuss key articles of the August issue of American Journal of Transplantation. #AJTHighlights ajthighlights.podbean.com

Functions and risks of aging-related diseases change nonlinearly across the human lifespan nature.com/articles/s4358…

🚨 New publication 🚨 Angiotensin II as a Vasopressor for Perioperative Hypotension in Solid Organ Transplant mdpi.com/2906840 #mdpibiomedicines via Biomedicines MDPI UIC Transplant Pharmacotherapy Team UIC Dept Pharmacy Practice

Check out our new manuscript sharing Mayo Clinic Arizona’s clinical experience with NMP. Compared to SCS, NMP was associated w ⬇️ Early allograft dysfunction ⬇️ Blood transfusions, OR time, AKI ⬇️ Length of stay and readmissions ⬆️ Graft and patient survival Amit K. Mathur, MD MS FACS

Large prospective study evaluates TruGraf & Viracor-TRAC for noninvasive kidney rejection diagnosis. While TruGraf & TRAC failed validation for rejection overall, TRAC shows promise for diagnosing AMR/mixed rejection with DSA in dysfunctional grafts tinyurl.com/3p7z45mb

The 2024 ILTS-ILCA consensus recommendations for liver transplantation for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. ILTS journals.lww.com/lt/abstract/99…

Are we discarding transplantable livers too soon? A new study shows that nonbiopsy assessments of donor liver fat (steatosis) are often too conservative — leading to up to 17% unnecessary liver discards. #TXPforAll #LiverTransplantation tinyurl.com/267h3fvu